BICO Group AB (publ) (STO:BICO)

Market Cap	1.21B -46.9%
Revenue (ttm)	1.78B +10.6%
Net Income	-684.00M
EPS	-9.69
Shares Out	70.57M
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	128,184
Average Volume	220,607
Open	17.22
Previous Close	17.17
Day's Range	17.07 - 17.58
52-Week Range	16.24 - 46.98
Beta	2.78
RSI	40.56
Earnings Date	Feb 18, 2026

About BICO Group AB

BICO Group AB (publ) provides hardware, laboratory automation, and software solutions in North America, Europe, Asia, and internationally. It operates through three segments: Bioprinting, Life Science Solutions, and Lab Automation. The Bioprinting segment offers 3D bioprinters and bioinks with a range of technologies for various applications, resolutions, and volume/speed requirements, as well as provides services focused on accelerating drug discovery and development. The Life Science Solutions segment supplies lab instrumentation, consumables...

• Industry: Medical Devices
• Sector: Healthcare
• Founded: 2016
• Employees: 586
• Stock Exchange: Nasdaq Stockholm
• Ticker Symbol: BICO

Financial Performance

In 2024, BICO Group AB's revenue was 1.95 billion, a decrease of -3.19% compared to the previous year's 2.01 billion. Losses were -5.50 million, -99.53% less than in 2023.